[1]Peng CH,Zhao SL,Jin JB.Application and evaluation of laparoscopic and robotic techniques in the treatment of malignant liver tumors[J].Chin J Pra Sur,2016,36(6):610-614.
[2]Fang CH,Fang ZS.Research progress of two stage hepatectomy combined with hepatic disconnection and portal vein ligation for treatment of hepatic malignancies[J].J Pra Med,2015,11:1733-1735.[方驰华,方兆山.联合肝脏离断和门静脉结扎的二步肝切除术治疗肝恶性肿瘤的研究进展[J].实用医学杂志,2015,11:1733-1735.]
[3]Hua YQ,Chen H,Meng ZQ,et al.Analysis of risk factors for tumor residual in 302 cases of hepatic malignancies treated by ultrasound-guided radiofrequency ablation[J].Chin J Cancer,2014,24(2):119-127.[花永强,陈颢,孟志强,等.超声引导射频消融治疗肝脏恶性肿瘤302例肿瘤残留危险因素分析[J].中国癌症杂志,2014,24(2):119-127.]
[4]Zheng FY,Wang JJ,Fu CM,et al.Advances in studies on chemical constituents and pharmacological actions of scutellaria baicalensis georgi[J].Proprietary Chinese Medicine,2016,38(1):141-147.[郑勇凤,王佳婧,傅超美,等.黄芩的化学成分与药理作用研究进展[J].中成药,2016,38(1):141-147.]
[5]Hang YY,Huang W,Sun R.Advances in pharmacological and toxicological effects of Bupleurum saponin on liver[J].Chin J lab Med,2011,17(17):298-301.[黄幼异,黄伟,孙蓉.柴胡皂苷对肝脏的药理毒理作用研究进展[J].中国实验方剂学杂志,2011,17(17):298-301.]
[6]Wang XL,Zheng Z,Hong ZY,et al.Advances in studies on chemical constituents and quality control of Rhizoma Corydalis[J].Lishizhen Medicine and Chinese Medicine,2011,22(1):227-229.[王晓玲,郑振,洪战英,等.中药延胡索的化学成分与质量控制研究进展[J].时珍国医国药,2011,22(1):227-229.]
[7]Huang ZG,Yang SZ,Jie ZH,et al.Analysis of factors affecting the clinical efficacy and hepatic infection in patients with liver tumor after radiofrequency ablation[J].Chin J Nosocomiology,2016,6(3):638-640.[黄志刚,杨世忠,揭中华,等.射频消融术对肝脏肿瘤患者临床疗效及肝内感染的影响因素分析[J].中华医院感染学杂志,2016,6(3):638-640.]
[8]Yang FK,Chen DL.Study of CT guided radiofrequency ablation localization of liver tumor[J].Chin J Minimally Invasive Surgery,2014,14(2):105-108.[杨福奎,陈德路.CT导向肝脏肿瘤射频消融病灶定位的研究[J].中国微创外科杂志,2014,14(2):105-108.]
[9]Li CH,Su K,Luo KX.MRI imaging features and diagnostic value of hepatic lesions[J].Chin J CT and MRI,2016,14(10):83-85.[李春宏,苏凯,罗康新.肝脏Ⅳ病变肿瘤的MRI影像学特征及诊断价值研究[J].中国CT和MRI杂志,2016,14(10):83-85.]
[10]Xia YS,Wang JH,Song XR,et al.Clinical study on the treatment of liver metastasis of digestive tract tumor with Sheng He San combined with interventional therapy[J].Lishizhen Med Mater Med Res,2001,12(8):3-5.
[11]Yang JY.The relationship between enhanced spiral CT features and the expression of VEGF,PLGF and MVD in hepatocellular carcinoma[J].Chin J Medical Imaging,2011,19(4):272-278.[杨军妍.肝细胞癌螺旋CT增强征象与其VEGF、PLGF和MVD表达的关系[J].中国医学影像学杂志,2011,19(4):272-278.]
[12]Zhou BY,Zheng J,Hou JC,et al.Expression of HMGB1 in hepatocellular carcinoma and its relationship with VEGF and MVD[J].J Chongqing Medical University,2012,37(5):409-412.
[13]Lu LP,Huang YF.The value of 4 tumor markers AFP,GPC3,DCP and VEGF in serum for early diagnosis of primary liver cancer[J].J Practical Cancer,2016,31(9):1399-1401.[卢凌鹏,黄艳芳.血清中AFP、GPC3、DCP和VEGF 4种肿瘤标志物对原发性肝癌的早期诊断价值[J].实用癌症杂志,2016,31(9):1399-1401.]
[14]Huang LP,Xie LM,Tang SS,et al.Application of real time contrast-enhanced ultrasonography in differential diagnosis of liver malignancies[J].Chinese J Ultrasound Medicine,2007,23(2):134-136.[黄丽萍,解丽梅,唐少珊,等.实时超声造影对肝脏恶性肿瘤鉴别诊断的应用研究[J].中国超声医学杂志,2007,23(2):134-136.]